An Incredible Team

taking big strides

Our Story

Boragen was founded by world-renowned chemists, Dr. Stephen Benkovic, Dr. Lucy Shapiro, Dr. Paul Schimmel, Dr. Gerald Fink, and Dr. C. Tony Liu, in late 2015 as a spinout of Pennsylvania State University with the vision to expand the boron platform to address unmet needs and challenges across multiple sectors.

We are a team united through the study and formulation of boron as a springboard for unique application in the enhancement of plant, animal, and human health. We are dedicated investigators, inventors and innovators. Our purpose is to bring a one-of-a-kind expertise as world leaders in boron chemistry. We do not limit ourselves; we empower our industry through innovation. 


Marissa Aubrey, PhD

Senior Research Chemist/IP Analyst

Brittany Frederick

Research Associate

Yvonne Freund, PhD

Sr. Director of Immunology

Rich Gianni

CFO & Controller

Chris Hahne

Plant Pathologist

Ashley-Beth Holmes, PHR

Head of People Operations

Sarah Jacobs, PhD

Sr. Scientist, Immunology

Bennett Jeffreys

Greenhouse Technician

Roger Kemble, PhD

Chief Executive Officer, SAB

C. Tony Liu, PhD

Chief Scientific Officer & Co-Founder

Chunliang ‘CL’ Liu, PhD

Senior Chemist

Megan Mackowiak

Program Manager

Cari McGregor

Research Associate

Timothy Pastoor, PhD, DABT, ATS

SVP, Toxicology & Regulatory Affairs

Luke Steere, PhD

Senior Plant Pathologist/Field Scientist

Hannah M. Webb

Lead – Business Development

YK Zhang, PhD

VP of Chemistry

Yasheen Zhou, PhD

VP of Computational Chemistry


Stephen Benkovic, PhD

Kristina Burow

Raj Kaul

Joel S. Marcus

Paul Schimmel, PhD


Peter Hertl, PhD

Jake Plattner, PhD

Robert Steffens, PhD

Mark Zettler, PhD

Dr. Brian Metcalf

backed by strong investors

Boragen's strategic investors receive no special rights for their investments.